Flicking through medical textbooks in 2022, our team spotted a surprising omission: a stark absence of images of health conditions on darker skin tones.

Bristol Myers Squibb Co. forecast 2025 sales and profit below Wall Street’s expectations — a sign that declining sales of ...

While 2024 was a so-so year for residential real estate the world of commercial real estate performance was the opposite. It’s a welcome respite from 2023.  At the year’s end, commercial transactions ...

Princess Royal thanks medics who looked after her following mystery incident involving a horse that left her concussed and badly bruised ...

Bristol Myers Squibb stock tumbled Thursday on a light outlook for 2025 following a strong fourth-quarter report.

Eros Pisano, a former teammate of Llyod Kelly at Bristol City, says he was ‘impressed’ by the Englishman’s physicality and versatility, even in the early stages of his career: ‘If he made it ...

Shares in Bristol-Myers Squibb fell more than 4% in premarket trading Thursday, after the drug maker gave 2025 guidance that undershot analyst expectations. Bristol expects sales of about $45.5 ...

BMS is not the only U.S. pharma giant making massive cuts. Last year, Pfizer revealed a similar plan to reduce $1.5 billion ...

The company forecast 2025 revenue of around $45.5 billion, down from $48.3 billion in 2024 and below analyst expectations of $47.4 billion, according to LSEG data. It forecast 2025 earnings in the ...

The company also issued a 2025 guidance that fell short of expectations, as some of the company’s older drugs face ...

The drugmaker Bristol Myers Squibb has been a standout among its big pharma peers over the past six months, scoring a ...